Company intelligence / Profile preview

Alithea Genomics

Epalinges, Switzerlandalitheagenomics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Alithea Genomics provides commercialized high-throughput RNA sequencing solutions that enable large-scale gene expression studies. Their technologies are used in drug screening, biomarker discovery, and biomedical research. No clinical trial results as they do not develop therapeutics themselves.

Modalities: RNA sequencing (RNA-seq)transcriptomics platforms; not directly therapeutic but enabling for drug discovery and biomarker research
Industry: Molecular Diagnostics

Partnerships

Collaborates with pharmaceutical companies and academic institutions for large-scale transcriptomic projects; specific names not disclosed in public sources.

Beyond the preview

Go deeper on Alithea Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alithea Genomics.

Explore the full profile